2m 2m 2m 2m 2m 2m 2m
TEVAPHARMIND SP ADR (TEVA)
NYSE
$31.93-$0.25 (-0.79%)
Price as of Jul 14, 2026 4:56 AM EDT- $38.4BMarket Cap
- 95.98%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TEVAPHARMIND SP ADR (TEVA)
$31.93-$0.25 (-0.79%)
TEVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.18 | ||
Change | -$0.77 (-2.34%) | ||
Open | $32.52 | ||
High | $32.81 | ||
Low | $32.14 | ||
Previous Close | $32.95 | ||
Volume | 4,231,528 | ||
30-Day Average Volume | 5,759,018 | ||
1-Week Change | -8.81% | ||
1-Month Change | -7.07% | ||
1-Year Change | 95.98% | ||
3-Year Change | 297.28% | ||
5-Year Change | 253.24% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $40.0B | ||
Market Cap | $38.4B | ||
Enterprise Value | $51.3B | ||
Period: QTR TTM FY | |||
Revenue | $4.0B | ||
Net Income | $369.0M | ||
Free Cash Flow | -$208.0M | ||
EBIT | $436.0M | ||
EBITDA | $675.0M | ||
Net Working Capital | $178.0M | ||
EPS | $0.31 | ||
Enterprise Value/EBITDA | 76 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 5 | ||
P/E | 106 | ||
PEG | -4 | ||
Price/Free Cash Flow | -184 | ||
Price/Operating Cash Flow | -959 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/27/2017 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/06/2002 | ||
Earnings & Revenue